US 12,097,207 · Application 17/547,496 · Granted Sep 24, 2024
US 12,097,207
Liver disease
Estimated expiration
November 13, 2039
13y 19d remaining
- Application 17001855 has not been granted a patent number
- Application 17001813 has not been granted a patent number
- Application 16554444 has not been granted a patent number
Earliest effective filing
Jul 19, 2019
+ 20 years
Jul 19, 2039
PTA +126d
Nov 22, 2039
TD cap (US 12,150,945)
Nov 13, 2039
Final
Nov 13, 2039
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- December 10, 2021
- Earliest effective filing
- July 19, 2019
- Issue date
- September 24, 2024
- PTA
- +126 days
- Base expiry (before PTA)
- July 19, 2039
July 19, 2019 + 20 years = July 19, 2039 + 126 PTA days = November 22, 2039
- Continuation of application 17/001,855, filed Aug 25, 2020
- Continuation of application 16/554,444, filed Aug 28, 2019
- Continuation of application 16/517,533, filed Jul 19, 2019, issued as US 12,150,945
- Continuation of application 16/517,533, filed Jul 19, 2019, issued as US 12,150,945
- Continuation of application 17/001,813, filed Aug 25, 2020
- Continuation of application 16/554,444, filed Aug 28, 2019
- Continuation of application 16/517,533, filed Jul 19, 2019, issued as US 12,150,945
- Continuation of application 16/554,444, filed Aug 28, 2019
- Continuation of application 16/517,533, filed Jul 19, 2019, issued as US 12,150,945
- PRO62/701,309 — Provisional — not used for base term
- PRO62/714,968 — Provisional — not used for base term
- PRO62/728,580 — Provisional — not used for base term
- PRO62/783,190 — Provisional — not used for base term
- PRO62/793,724 — Provisional — not used for base term
- PRO62/701,309 — Provisional — not used for base term
- PRO62/714,968 — Provisional — not used for base term
- PRO62/728,580 — Provisional — not used for base term
- PRO62/783,190 — Provisional — not used for base term
- PRO62/793,724 — Provisional — not used for base term
- PRO62/701,309 — Provisional — not used for base term
- PRO62/714,968 — Provisional — not used for base term
- PRO62/728,580 — Provisional — not used for base term
- PRO62/783,190 — Provisional — not used for base term
- PRO62/793,724 — Provisional — not used for base term
- PRO62/701,309 — Provisional — not used for base term
- PRO62/714,968 — Provisional — not used for base term
- PRO62/728,580 — Provisional — not used for base term
- PRO62/783,190 — Provisional — not used for base term
- PRO62/793,724 — Provisional — not used for base term
- PRO62/701,309 — Provisional — not used for base term
- PRO62/714,968 — Provisional — not used for base term
- PRO62/728,580 — Provisional — not used for base term
- PRO62/783,190 — Provisional — not used for base term
- PRO62/793,724 — Provisional — not used for base term
Terminal disclaimers
TD caps expiration to November 13, 2039 (earliest expiring referenced patent: US 12,150,945)
US 12,097,207· Application 17/547,496(from application 17/547,496)Capping patent
Liver disease
- Filing date
- Dec 10, 2021
- Earliest effective filing
- Jul 19, 2019
- Issue date
- Sep 24, 2024
- PTA
- +126 days
- Calculated expiration
- Nov 22, 2039
Continuation of 17/001,855, filed Aug 25, 2020
Continuation of 16/554,444, filed Aug 28, 2019
Continuation of 16/517,533, filed Jul 19, 2019, issued as US 12,150,945
Continuation of 16/517,533, filed Jul 19, 2019, issued as US 12,150,945
Continuation of 17/001,813, filed Aug 25, 2020
Continuation of 16/554,444, filed Aug 28, 2019
Continuation of 16/517,533, filed Jul 19, 2019, issued as US 12,150,945
Continuation of 16/554,444, filed Aug 28, 2019
Continuation of 16/517,533, filed Jul 19, 2019, issued as US 12,150,945
Jul 19, 2019 + 20y + 126d PTA = Nov 22, 2039
US 12,150,945· Application 16/517,533(from application 16/517,533)Capping patent
Liver disease
- Filing date
- Jul 19, 2019
- Earliest effective filing
- Jul 19, 2019
- Issue date
- Nov 26, 2024
- PTA
- +117 days
- Calculated expiration
- Nov 13, 2039
Jul 19, 2019 + 20y + 117d PTA = Nov 13, 2039
US APP:17001855(from application 17/001,855)
Could not resolve calculation details
US APP:17001813(from application 17/001,813)
Could not resolve calculation details
US APP:16554444(from application 16/554,444)
Could not resolve calculation details
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 17/547,496 · US 12,097,207
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 12,097,207: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US12097207Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.